SPIN 2025 Congress

The SPIN 2025 Congress, the 8th edition of the Skin Inflammation & Psoriasis International Network (SPIN), took place from July 2 to 4, 2025, at the Beffroi de Montrouge in Paris, France. This premier international event brought together dermatologists, rheumatologists, researchers, and patient advocates to address the latest advances in chronic inflammatory skin diseases, including psoriasis, atopic dermatitis, alopecia areata, hidradenitis suppurativa, vitiligo, and psoriatic arthritis.

SPIN is an independent, non-profit international network dedicated to improving the quality of life for patients with these conditions through education, research, expert consensus, and global collaboration. The 2025 congress served as a vital platform for sharing cutting-edge science, clinical guidelines, and real-world strategies in an era of rapidly evolving targeted therapies.

Mission and Scope of SPIN

SPIN’s core mission is to bridge gaps in care for chronic inflammatory skin diseases by fostering international dialogue, developing practical clinical tools, and addressing unmet medical needs. The network supports:

• Education through e-learning modules (SPIN Fundamentals)
• Research initiatives and white papers
• National and regional expert networks
• Patient-centered approaches

The 2025 congress reflected this mission by covering both scientific breakthroughs and practical implementation of new treatments across multiple diseases.

Key Highlights of SPIN 2025

The scientific program featured plenary lectures, symposia, abstract presentations, and interactive sessions. Major themes included:

Psoriasis and Psoriatic Arthritis

• Precision medicine approaches and personalized treatment selection
• Long-term safety and real-world evidence of IL-17, IL-23, and JAK inhibitors
• Management of difficult-to-treat areas (scalp, nails, genitals, palms/soles)
• Cardiovascular risk reduction and lifestyle interventions

Atopic Dermatitis

• New and emerging biologics and JAK inhibitors
• Management in special populations (pregnancy, children, elderly)
• Itch control and quality-of-life strategies
• Combination therapies and treatment sequencing

Other Inflammatory Skin Diseases

• Alopecia areata: JAK inhibitors and emerging options
• Hidradenitis suppurativa: Surgical and medical advances
• Vitiligo: Repigmentation strategies and new targeted therapies

The congress emphasized multidisciplinary care, patient-reported outcomes, and the integration of new therapies into everyday clinical practice.

Scientific and Clinical Impact

SPIN 2025 highlighted several important developments:

• Updated international guidelines for psoriasis and atopic dermatitis
• Growing evidence on the systemic nature of these diseases and the need for holistic management
• Advances in understanding disease mechanisms through biomarkers and imaging
• Focus on health equity and access to innovative treatments in different regions

The meeting also addressed practical challenges such as treatment adherence, cost-effectiveness, and long-term safety monitoring.

Why SPIN Matters

Chronic inflammatory skin diseases significantly impact patients’ physical health, mental well-being, and social functioning. SPIN plays a unique role by:

• Bringing together experts from dermatology, rheumatology, and immunology
• Promoting evidence-based consensus across borders
• Supporting younger clinicians and researchers through abstract sessions and awards
• Encouraging patient involvement in research and guideline development

How to Stay Connected and Learn More

Professionals and patients can access:

• SPIN’s official website: www.spindermatology.org
• SPIN e-learning platform (SPIN Fundamentals)
• Congress abstracts and recordings (when available)
• National SPIN networks in various countries

The next edition of the congress is expected to continue building on the success of SPIN 2025.

Frequently Asked Questions (FAQ)

1. What is SPIN?
   The Skin Inflammation & Psoriasis International Network is a global organization focused on improving care for patients with chronic inflammatory skin diseases through education, research, and collaboration.
2. When and where was SPIN 2025 held?
   July 2–4, 2025, at the Beffroi de Montrouge in Paris, France.
3. What topics were covered at SPIN 2025?
   Psoriasis, psoriatic arthritis, atopic dermatitis, alopecia areata, hidradenitis suppurativa, vitiligo, and related inflammatory conditions.
4. Who should attend SPIN Congress?
   Dermatologists, rheumatologists, researchers, nurses, pharmacists, and patient representatives interested in inflammatory skin diseases.
5. How can I access SPIN resources?
   Visit www.spindermatology.org for e-learning, guidelines, and network information.

Conclusion

The SPIN 2025 Congress reinforced the importance of international collaboration in advancing the understanding and management of chronic inflammatory skin diseases. As new targeted therapies continue to transform patient outcomes, events like SPIN provide essential platforms for knowledge exchange, guideline development, and addressing real-world challenges in clinical practice.

For healthcare professionals and patients alike, staying engaged with SPIN offers access to the latest evidence and practical tools needed to deliver optimal care in this rapidly evolving field.

Key Resources